Population
Patients with or at risk for methamphetamine-associated cardiomyopathy (MAC)
Design
Review
Authors
Loading...
Alerts clinicians to rising methamphetamine cardiomyopathy; leaves open gaps in incidence, risk factors, therapy, and prognosis.
Highlights the growing clinical importance of methamphetamine-associated cardiomyopathy and the need for further research into its management and prognosis.
Won et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: